Authors
Loading...
Randomized trial identifies CCR5 inhibitor ZINC000000867238 in novel compounds, suggesting potential as HIV-1 blocker.
Kumar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: